미국의 조영제 및 방사성 의약품 시장 : Medtech 360

The US contrast agents and radiopharmaceutical market will see moderate growth over the forecast period. Market growth will be driven by rising PET and MRI procedure volumes, and the expanding use of imaging agents in CEUS and PET procedures. However, the market will be somewhat limited by the continued concern over gadolinium and radiation exposure in certain modalities. Additionally, the shift toward value-based care will act as a barrier for certain procedures, favoring those that offer the highest levels of accuracy and clarity in visualization instead. Moving forward, market growth will be driven by the introduction of new contrast agents currently in development or undergoing clinical trials, along with FDA approvals for expanded indications of existing contrast agents.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for contrast agents and radiopharmaceuticals in the US from 2019 through 2033.

There has been a gradual increase in the number FDA approvals for PSMA PET imaging agents.

• Which PET imaging agents have received FDA approval?
• What advantages do these PSMA PET imaging agents offer?
• What indications are they approved for?

Manufacturers are actively engaging in ongoing clinical evaluation of their contrast agent products.

• Which contrast agent products are under clinical evaluation?
• What advantage do they offer over the existing contrast agents in the market.

The FDA expanded approval for the use of CEUS in radiology procedures.

• What type of procedures does this approval extend to? What additional procedures could be approved in the future?
• Which contrast agents have received FDA approval?
• How will these FDA approvals change the competitive landscape.

Looming concerns over the effects of gadolinium retention will negatively affect the use of contrast-enhanced MRI.

• How are ACOs, health networks, and physicians responding to the recent findings on gadolinium retention?
• What are the key differences between linear and macrocyclic GBCAs, and how will market demand for these products shift going forward?
• Will other imaging modalities cannibalize contrast-enhanced MRI procedures?
• Which companies (and associated products) will benefit from the shift to macrocyclic GBCAs?

Table of Contents

United States

Abstract

Executive Summary

• COVID-19 Updates
• Market Highlights
• Competitive Highlights
• Market Developments
• Procedures and Products Covered

Key Report Updates

Contrast Agent and Radiopharmaceutical Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • Cardinal Health
  • GE Healthcare
  • Bracco Group
  • Lantheus Holdings
  • Bayer Healthcare
  • Other Key Competitors
  • Factors Affecting All Competitors
• Market Developments

Radiopharmaceutical Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • US Radiopharmaceutical Market Competitive Insights

CT and X-Ray Contrast Agent Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • US CT and X-Ray Contrast Agent Market Competitive Insights

MRI Contrast Agent Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • US MRI Contrast Agent Market Competitive Insights
  • Factors Affecting All Competitors

Ultrasound Contrast Agent Market

• Market Highlights
  • Key Content Updates
• Market Definitions
• Market Forecast Data
• Market Shares
• Competitive Insights
  • US Ultrasound Contrast Agent Market Competitive Insights

Appendix

• Abbreviations
• Bibliography

Tables and Figures

• Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
• Contrast Agent and Radiopharmaceutical Market Landscape, US (USD), 2023 and 2033
• Competitive Insights
• Contrast Agent and Radiopharmaceutical Market Share Rankings, by Product Type, US, 2023
• Companies Mentioned
• Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
• Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
• Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
• Contrast Agent and Radiopharmaceutical Procedures and Products Covered, US
• US Contrast Agent and Radiopharmaceutical Market Drivers
• US Contrast Agent and Radiopharmaceutical Market Limiters
• Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
• Contrast Agent and Radiopharmaceutical Procedures, by Product Type, US, 2019-2033
• Contrast Agent and Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
• Contrast Agent and Radiopharmaceutical Revenue Market Shares, US, 2023
• Contrast Agent and Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
• Cardinal Health Competitive Insights
• GE Healthcare Competitive Insights
• Bracco Group Competitive Insights
• Lantheus Holdings Competitive Insights
• Bayer Healthcare Competitive Insights
• Competitive Insights for Other Key Competitors
• Recent Events in the Contrast Agent and Radiopharmaceutical Market, US
• Key Clinical Trials in the Contrast Agent and Radiopharmaceutical Market, US
• Emerging Products for the Contrast Agent and Radiopharmaceutical Market, US
• US Radiopharmaceutical Market Drivers
• US Radiopharmaceutical Market Limiters
• Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
• Radiopharmaceutical Market, by Product Type, US (USD), 2019-2033
• Radiopharmaceutical Market Growth, by Product Type, US, 2020-2033
• Nuclear Medicine System Installed Base, by Product Type, US, 2019-2033
• Radiopharmaceutical Revenue Market Shares, US, 2023
• Radiopharmaceutical Revenue Market Shares, by Product Type, US, 2023
• US CT and X-Ray Contrast Agent Market Drivers
• US CT and X-Ray Contrast Agent Market Limiters
• CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
• CT and X-Ray Contrast Agent Market, by Product Type, US (USD), 2019-2033
• CT and X-Ray Contrast Agent Market Growth, by Product Type, US, 2020-2033
• CT and X-Ray System Installed Base, by Product Type, US, 2019-2033
• CT Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
• CT Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
• X-Ray, Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
• CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
• CT and X-Ray Contrast Agent Revenue Market Shares, US, 2023
• US MRI Contrast Agent Market Drivers
• US MRI Contrast Agent Market Limiters
• MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
• MRI Contrast Agent Market, by Procedure Type, US (USD), 2019-2033
• MRI Contrast Agent Market Growth, by Procedure Type, US, 2020-2033
• MRI System Installed Base, US, 2019-2033
• MRI Contrast Agent Revenue Market Shares, US, 2023
• MRI Contrast Agent Revenue Market Shares, US, 2023
• US Ultrasound Contrast Agent Market Drivers
• US Ultrasound Contrast Agent Market Limiters
• Ultrasound Contrast Agent Market, US (USD), 2019-2033
• Ultrasound Contrast Agent Market, US (USD), 2019-2033
• Ultrasound Contrast Agent Revenue Market Shares, US, 2023
• Ultrasound Contrast Agent Revenue Market Shares, US, 2023